These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 24119342)

  • 21. A severe valproate overdose with complete recovery in a newborn.
    Grynnerup A; Fernández IS; Hernández JC; Martínez AD; López JM; García-Alix A
    J Child Neurol; 2012 Aug; 27(8):1072-6. PubMed ID: 22433424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperammonemic encephalopathy related to valproate, phenobarbital, and topiramate synergism.
    Gomez-Ibañez A; Urrestarazu-Bolumburu E; Viteri-Torres C
    Epilepsy Behav; 2011 Aug; 21(4):480-2. PubMed ID: 21700501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lamotrigine might potentiate valproic acid-induced hyperammonemic encephalopathy.
    Fan CC; Huang MC; Liu HC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1747-8. PubMed ID: 18602440
    [No Abstract]   [Full Text] [Related]  

  • 24. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y; Annagur BB; Sayin AA; Akbaba N
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract]   [Full Text] [Related]  

  • 25. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
    Deutsch SI; Burket JA; Rosse RB
    Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproate-induced hyperammonemic encephalopathy: a brief review.
    Lewis C; Deshpande A; Tesar GE; Dale R
    Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproate-induced hyperammonemic encephalopathy.
    Yehya N; Saldarini CT; Koski ME; Davanzo P
    J Am Acad Child Adolesc Psychiatry; 2004 Aug; 43(8):926-7. PubMed ID: 15266186
    [No Abstract]   [Full Text] [Related]  

  • 32. Valproate-induced hyperammonemic encephalopathy.
    Verrotti A; Trotta D; Morgese G; Chiarelli F
    Metab Brain Dis; 2002 Dec; 17(4):367-73. PubMed ID: 12602513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
    Abreu LN; Issler C; Lafer B
    Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
    [No Abstract]   [Full Text] [Related]  

  • 34. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproate-induced hyperammonemic encephalopathy followed by benzodiazepine withdrawal in a patient with schizoaffective disorder: a differential diagnosis.
    Sarlon J; Hess E; Krasnianski A
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E69-70. PubMed ID: 24026753
    [No Abstract]   [Full Text] [Related]  

  • 37. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
    Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
    Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 39. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
    Dealberto MJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK; Gazioğlu S
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.